- E27.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E27.5 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E27.5 – other international versions of ICD-10 E27.5 may differ.
ICD-10-CM E27.5 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Adrenomedullary hyperplasia
- Catecholamine hypersecretion
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E27.5:
- medulla > adrenal cortex, not associated with Cushing\’s syndrome E27.0
- adrenomedullary > medulla E27.5
- adrenomedullary > Hyperplasia, hyperplastic
- adrenaline > Hypersecretion
- adrenomedullary > Hypersecretion
- catecholamine > Hypersecretion
- epinephrine > Hypersecretion
- medulloadrenal > Hypersecretion
- medulla > adrenal
- catecholamine > Overproduction
- catecholamine, by pheochromocytoma > Secretion
- pheochromocytoma > by E34.0